Registries are among the most valuable evidence programs a life sciences organization can run. Across sites, modalities, and years of follow-up, they capture the longitudinal imaging that reveals how disease progresses and how patients respond over time. When a registry runs on the right purpose-built platform, all of that value is captured, structured, and preserved from the very first scan.
That is exactly what Yunu delivers today.
- Collect and hold imaging from sites anywhere in the world, with automatic de-identification at upload for both DICOM and non-DICOM data—no portals, no installs, no licenses.
- Preserve original, longitudinal imaging data in full fidelity, complete with measurements, annotations, and provenance.
- Maintain a single, standardized, searchable repository, independent of any site PACS.
- Export and share de-identified datasets on demand for analysis or collaboration.
- Stay inspection-ready and 21 CFR Part 11 compliant, with complete traceability from first scan to lock.
Start a registry program in a fraction of the time and cost
Traditional registry imaging leans on stitched-together storage and manual, people-driven reconciliation, which is slow to stand up, costly to maintain, and fragile the moment a key team member moves on. Yunu takes a software-forward approach as a purpose-built, longitudinal platform that lets you launch a registry program quickly and confidently, in as little as a tenth of the time and cost you may be used to. Setup takes minutes, not months, with no upfront software fees. It is better, faster, and more cost-effective because it runs on modern technology and longitudinal data management rather than manual processes, spreadsheets, and disconnected drives.
Longitudinal by design: run the trial and build the registry at once
An ideal platform for registry programs, Yunu’s registry-grade preservation is a natural byproduct of running a trial on Yunu, not a separate project to tackle later.
Because Yunu is built for longitudinal imaging, every timepoint, every assessment, and every site is captured and stored in the structured, traceable format a registry requires automatically, as the study runs. A single patient timepoint can generate more than 1,200 structured imaging data elements, and Yunu keeps all of it organized, searchable, and linked to its clinical context. Reconciliation that once consumed months takes days, because the work happens continuously rather than being reconstructed after the fact.
Just as important, the platform manages the data, not tribal knowledge held by individuals. That eliminates a quiet but serious risk in long-running registries: staff turnover. What is tracked in Yunu stays traceable, compliant, and complete no matter who joins or leaves the team, so the asset is always ready when you need it.
Value that compounds over time
When imaging data is preserved this way, it keeps working long after the original study closes. Well-managed registry imaging becomes a foundation for real-world evidence, label-expansion opportunities, novel biomarker discovery, and the high-quality datasets that AI, radiomics, and advanced analytics depend on. Quality, context, and provenance determine how far the data can take you.
Regulators increasingly recognize this value, and modern frameworks reinforce it. Yunu is designed to support evolving expectations for data integrity, traceability, and protection of personal information, including ICH E6(R3), and meets FDA 21 CFR Part 11, HIPAA, SOC 2 Type II, and GDPR standards. ² Running your registry on Yunu means those expectations are met by design.
Proven at scale
Yunu supports more than 5,000 active clinical trials and manages the data of 400+ pharmaceutical companies, helping sponsors manage imaging with consistency, traceability, and long-term usability. With imaging as the primary endpoint for a wide range of therapeutic areas and over 90% of oncology trials alone, the organizations that treat imaging as a durable, reusable asset will be the ones best positioned to lead. ¹
Imagine it in your environment
Picture your next registry: launched in a fraction of the time, every image captured correctly at the source, every timepoint preserved in full fidelity, every dataset ready to answer questions you haven’t even asked yet. That is not a future state; it is what Yunu does for sponsors today. The only question is what your imaging data could unlock once it is preserved as the strategic asset it already is.
References
1. ClinicalTrials.gov. Trends and Charts on Registered Studies. U.S. National Library of Medicine. Accessed June 19, 2026.
2. International Council for Harmonisation. ICH Harmonised Guideline: Good Clinical Practice E6(R3). Final Guideline. January 6, 2025.
Contact us today to schedule a demo.
